Trials / Conditions / Thymoma and Thymic Carcinoma

Thymoma and Thymic Carcinoma

12 registered clinical trials studyying Thymoma and Thymic Carcinoma — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	6 vs 3 Cycles of Neoadjuvant Chemotherapy for Potentially Resectable Locally Advanced Thymic Epithelial Tumors NCT07463313	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	Phase 2 / Phase 3
Recruiting	IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Asse NCT06790706	Hospices Civils de Lyon	Phase 2
Recruiting	Hypofractionated Radiotherapy for Thymic Epithelial Tumors NCT06692062	Rongrong Zhou	N/A
Recruiting	Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma NCT02633514	Fudan University	Phase 3
Recruiting	Artificial Intelligence Prediction Tool in Thymic Epithelial Tumors NCT06301945	Erasmus Medical Center	—
Unknown	Chemotherapy Combined With Pembrolizumab in Treating Patients With Thymoma and Thymic Carcinoma NCT04554524	Tang-Du Hospital	Phase 4
Unknown	Hypofractionated Chemoradiotherapy and Thymosin α1 in Unresectable or Recurrent Thymic Epithelial Tumor NCT03663764	Sun Yat-sen University	Phase 2
Completed	Chemoradiotherapy for Limited Advanced Unresectable Thymic Epithelial Tumors NCT02636556	Fudan University	N/A
Completed	Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Chemotherapy NCT02049047	Armando Santoro, MD	Phase 2
Completed	Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breas NCT00372840	Fox Chase Cancer Center	N/A
Completed	Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer NCT00024076	Jonsson Comprehensive Cancer Center	Phase 2
Completed	Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma NCT00003283	Eastern Cooperative Oncology Group	Phase 2